Abstract
This report analyzes the worldwide markets for Autoimmune Disease Therapeutics
in US$ Billion by the following therapeutic class - Rheumatoid Arthritis,
Multiple Sclerosis, Psoriasis, Crohn' s Disease (Biologics only), and Others.
The report provides separate comprehensive analytics for the US, Japan,
Europe, and Rest of World. Annual forecasts are provided for each region for
the period 2006 through 2015. The report profiles 115 companies including many
key and niche players worldwide such as Abbott Laboratories, Amgen Inc., Bayer
Schering Pharma AG, Biogen Idec Inc., Bristol-Myers Squibb Company, Elan
Corporation, plc, Eli Lilly And Company, F. Hoffmann-La Roche AG, Chugai
Pharmaceutical Co., Ltd., Genentech, Inc., GlaxoSmithKline plc, Johnson &
Johnson, Inc., Merck Serono SA, Novartis AG, Sanofi-aventis SA ,
Schering-Plough Corporation, Shire Pharmaceuticals Group plc, Teva
Pharmaceuticals Industries Limited, and UCB Pharma. Market data and analytics
are derived from primary and secondary research. Company profiles are mostly
extracted from URL research and reported select online sources.
| 
View Cart
